Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Antilymphocyte Serum × 30 days × Clear all

Sponsor

Conditions

Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Recurrence 1 Rasmussen subacute encephalitis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myasthenia Gravis 1 Lambert-Eaton Myasthenic Syndrome 1 Hemoglobinuria, Paroxysmal 1 Hematologic Neoplasms 1 Congenital amegakaryocytic thrombocytopenia 1 Bone Marrow Failure Disorders 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1 Anemia, Hypochromic 1 Anemia, Diamond-Blackfan 1

Interventions

Cyclophosphamide 7 fludarabine phosphate 6 fludarabine 6 Whole-Body Irradiation 5 Mycophenolic Acid 4 asciminib 3 Mesna 3 Melphalan 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Dasatinib 3 nilotinib 2 bosutinib 2 Tacrolimus 2 Stem Cell Transplantation 2 Cyclosporine 2 Busulfan 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ponatinib 1 blinatumomab 1 aldesleukin 1 Thiotepa 1 Succimer 1 Peripheral Blood Stem Cell Transplantation 1 Pentetic Acid 1 Patient Reported Outcome Measures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡